Back to INBX

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC → INBX

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC INBX Position History

Inhibrx Biosciences, Inc. • Healthcare

Quarters held
6
Latest value
$1.8M
Q3 2026
Peak value
$1.9M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$790
Q1 2026$5K
Q2 2026$6K
Q2 2026$1.9M
Q3 2026$60K
Q3 2026$1.8M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$1.8M18.3K——
Q3 2026$60K599——
Q2 2026$1.9M20.0K——
Q2 2026$6K67——
Q1 2026$5K67——
Q4 2025$79010——

Other funds holding INBX

Other UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC positions

NVDA

NVIDIA CORPORATION

$14.5B
NVDA

NVIDIA CORPORATION

$13.7B
NVDA

NVIDIA CORPORATION

$13.1B
NVDA

NVIDIA CORPORATION

$12.8B
MSFT

MICROSOFT CORP

$12.5B
NVDA

NVIDIA CORPORATION

$12.1B
AAPL

APPLE INC

$11.2B
MSFT

MICROSOFT CORP

$10.1B
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC INBX Holdings: 13F Position History | Track13F